COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,803 Articles (22,527 medRxiv, 8,276 bioRxiv)

Most recent first Previous |  Page 185: Articles 1841-1850  | Next

N-protein vaccine Convacell(R) is effective against COVID-19: phase 3, randomized, double-blind, placebo-controlled clinical trial
Rabdano, S. O., Ruzanova, E. A., Vertyachikh, A. E., Teplykh, V. A., Emelyanova, A. B., Rudakov, G. O., Arakelov, S. A., Pletyukhina, I. V., Saveliev, N. S., Lukovenko, A. A., Fakhretdinova, L. N., Safi, A. S., Zhirenkina, E. N., Polyakova, I. N., Belozerova, N. S., Klykov, V. V., Savelieva, A. P., Ekimov, A. A., Merkulov, V. A., Yudin, S. M., Kruchko, D. S., Berzin, I. A., Skvortsova, V. I., Clinical Trial Group
10.1101/2024.04.01.24304717 — Posted: 2024-04-09
Integrative Systems Immunology Analysis Reveals Elevated Anti-AGTR1 Levels with Accumulating COVID-19 Symptoms
Fonseca, D. L. M., Japel, M., Filgueiras, I. S., Baiochi, G. C., Ostrinski, Y., Halpert, G., Lavi, Y. B., Vojdani, E., e Silva, J. C. S., Usuda, J. N., Freire, P. P., Nobile, A. L., Adri, A. S., Marcal, P. B., Correa, Y. L. G., do Vale, F. Y. N., Lopes, L. O., Schmidt, S. L., Wang, X., Vahldieck, C., Fels, B., Schimke, L. F., Hirata, M. H., Miranda, G. C., AKhan, T. A., Catar, R., Moll, G., Silva-Sousa, T., Yu, Y.-R. A., Dalmolin, R. J., Amital, H., Vojdani, A., Nakaya, H., Ochs, H. D., Silverberg, J. I., Zimmerman, J., Zyskind, I., Rosenberg, A. Z., Schulze-Forster, K., Heidecke, H., Hackel
10.1101/2024.04.05.24305287 — Posted: 2024-04-09
Comparative Application of the Fluctuation Test to the data of Morbidity by COVID-19 in United States of America, United Kingdom, Taiwan and China 2020-2023
Lopez, A. Y., Grassi, H. C., Andrades, E. J., Andrades, J. E.
10.1101/2024.04.06.24305422 — Posted: 2024-04-08
Transcriptome landscape of high and low responders to an inactivated COVID-19 vaccine after 4 months using single-cell sequencing
Zhu, Z., Huang, Y., Sun, J., Li, M., Chen, Y., Zhang, L., Huang, F., Liu, C., Weijun, C., Ma, J.
10.1101/2024.04.07.24305443 — Posted: 2024-04-08
Quantifying the Regional Disproportionality of COVID-19 Spread
Sasaki, K., Ikeda, Y., Nakano, T.
10.1101/2024.04.05.24305413 — Posted: 2024-04-07
Spatial proteomics identifies a novel CRTC-dependent viral sensing pathway that stimulates production of Interleukin-11
Ravenhill, B. J., Oliveira, M., Wood, G., Di, Y., Davies, C., Lu, Y., Antrobus, R., Elliott, G., Irigoyen, N., Hughes, D. J., Lyons, P., Chung, B. Y., Borner, G., Weekes, M. P.
10.1101/2024.04.04.588067 — Posted: 2024-04-07
Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain
Ying, B., Liang, C.-Y., Desai, P., Scheaffer, S., Elbashir, S., Edwards, D. K., Thackray, L. B., Diamond, M. S.
10.1101/2024.04.05.588051 — Posted: 2024-04-07
Epitope-anchored contrastive transfer learning for paired CD8+ T cell receptor-antigen recognition
Zhang, Y., Wang, Z., Jiang, Y., Littler, D. R., Gerstein, M., Purcell, A. W., Rossjohn, J., Ou, H.-Y., Song, J.
10.1101/2024.04.05.588255 — Posted: 2024-04-07
Direct genome sequencing of respiratory viruses from low viral load clinical specimens using target capture sequencing technology
Takemae, N., Kuba, Y., Oba, K., Kageyama, T.
10.1101/2024.04.05.588295 — Posted: 2024-04-07
Antigenic cartography using hamster sera identifies SARS-CoV-2 JN.1 evasion seen in human XBB.1.5 booster sera
WANG, W., Bhushan, G. L., Paz, S., Stauft, C. B., Selvaraj, P., Goguet, E., Bishop-Lilly, K. A., Subramanian, R., Vassell, R., Lusvarghi, S., Cong, Y., Agan, B., Richard, S. A., Epsi, N., Fries, A., Fung, C. K., Conte, M., Holbrook, M., Wang, T. T., Burgess, T. H., Mitre, E., Pollett, S., Katzelnick, L., Weiss, C. D.
10.1101/2024.04.05.588359 — Posted: 2024-04-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).